Friday 6 November 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.

Revenue: −0.24%
EPS: +2.48%
Free cash flow: +17.4%
Total debt: +37.5%

Quarter to June 2026, against a year earlier

81.72 7.48 −8.39%

Follow ZTS

Alert me

Market cap: $33.9B
P/E: 13.4×
Fwd P/E: 14.2×
Dividend yield: 2.59%
F-score: 7/9
Altman Z: 5.73
Beneish M: −2.45
Dividend safety: 88/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Zoetis Inc. (ZTS) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
U.S.	5,097	53.84%
International	4,254	44.94%
Other, not broken out	116	1.23%
Gross margin		71.84%
Operating margin		35.49%
Pre-tax margin		35.49%

Revenue by product or service $m

Line	FY2012	FY2011
Anti-infectives	1,268 29.24%	1,311 30.97%
Vaccines	1,108 25.55%	1,077 25.44%
Other pharmaceutical	710 16.37%	724 17.10%
Parasiticides	675 15.57%	645 15.24%
Medicated feed additives	403 9.29%	347 8.20%
Other Non Pharmaceuticals	144 3.32%	129 3.05%
Also reported: a second breakdown of the same revenue
Cattle	1,603 36.97%	1,617 38.20%
Dogs and Cats	1,328 30.63%	1,287 30.40%
Swine	592 13.65%	562 13.28%
Poultry	506 11.67%	501 11.84%
Horses	185 4.27%	168 3.97%
Sheep and other	94 2.17%	98 2.32%
Contract manufacturing & human health	28 0.65%	—
Companion Animal	1,513	1,455
Livestock	2,795	2,778
Revenue	4,336	4,233

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2014	FY2013	FY2012	FY2011
U.S.	5,097 53.84%	5,074 54.82%	4,555 53.31%	4,313 53.38%	4,042 51.98%	3,557 53.29%	3,203 51.17%	2,877 49.39%	2,620 49.37%	2,447 50.06%	—	—	—	—
International	4,254 44.94%	4,102 44.32%	3,911 45.77%	3,681 45.56%	3,652 46.97%	3,035 45.47%	2,972 47.48%	2,890 49.61%	2,643 49.80%	2,390 48.90%	—	—	—	—
Reportable	—	—	—	—	—	—	—	—	—	—	4,735 98.96%	4,508 98.84%	4,308 99.35%	4,233 100.00%
Other Segments	—	—	—	—	—	—	—	—	—	—	50 1.04%	53 1.16%	28 0.65%	0 0.00%
Other, not broken out	116 1.23%	80 0.86%	78 0.91%	86 1.06%	82 1.05%	83 1.24%	85 1.36%	58 1.00%	44 0.83%	51 1.04%	—	—	—	—
Revenue	9,467	9,256	8,544	8,080	7,776	6,675	6,260	5,825	5,307	4,888	4,785	4,561	4,336	4,233

Gross profit by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2014	FY2013	FY2012	FY2011
International	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
U.S.	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Gross profit	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2014	FY2012	FY2011
International	2,676 55.92%	—	—
United States	2,059 43.03%	1,776 40.96%	1,659 39.19%
Europe, Africa, Middle East	—	1,068 24.63%	1,144 27.03%
Canada and Latin America	—	769 17.74%	788 18.62%
Asia and Pacific	—	695 16.03%	642 15.17%
Other, not broken out	50 1.04%	28 0.65%	—
Revenue	4,785	4,336	4,233

Gross profit by segment $m, and margin

	FY2014	FY2012	FY2011
International	‡	‡	‡
United States	‡	‡	‡
Gross profit	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.

Zoetis Inc. (ZTS) revenue by segment, product and region

Where the money comes from and where it goes

Revenue by product or service $m

Revenue by segment $m

Gross profit by segment $m, and margin

Revenue by region $m

Gross profit by segment $m, and margin

Stockrow Weekly